Cyclosporine in the treatment of severe UC

يدور هذا النقاش حول Cyclosporine in the treatment of severe UC في قسم آخر المستجدات الطبية في الملتقى الطبي السوري; --> INTRODUCTION: Intravenous steroid therapy is the standard treatment in severe attacks of ulcerative colitis (UC), but 20% to 60% of patients fail to respond and require colectomy. Cyclosporine (CyA)
عودة   الملتقى الطبي السوري > أقسام طبية عامة > آخر المستجدات الطبية


القرحة القلاعية Aphthous Ulcersكلمة بكلمة مع مادة النسج (حمل المحاضرة الثالثة من فضلك)عندي مذاكرة تشريح 1 بكرى ومالي ملحق .......شو بدي اساوي؟!!!؟
استفسارات بخصوص الفيزيولوجياخلونا نحل اسئلة دورات الفيزيولوجيا سوا ...Go 


الرد
 
LinkBack أدوات الموضوع
  #1  
قديم Jan, 09 2006, 12:53
Philip Hardo
شاب - طب بشري - بعد التخرج
 
تاريخ الانتساب: Oct, 28 2005
المكان: uk
العمر: 56
المشاركات: 217
التشكرات: 1
مشكور 50 من المرات في 29 من المشاركات
Cyclosporine in the treatment of severe UC

INTRODUCTION: Intravenous steroid therapy is the standard treatment in severe attacks of ulcerative colitis (UC), but 20% to 60% of patients fail to respond and require colectomy. Cyclosporine (CyA) has shown efficacy in steroid failures and could avoid surgery, but controversy remains. Aim: The objective of this study was to conduct a systematic review to evaluate the effectiveness and safety of CyA in inducing remission in patients with a severe attack of UC. Methods: We did a systematic review using Cochrane methodology, including data from published (in English, French, Spanish or German) clinical trials done in adults using intravenous or oral CyA in UC. Data on efficacy are obtained from controlled and observational clinical trials, and for safety issues case reports are also considered.
RESULTS: 31 studies were identified which met the inclusion criteria, 22 (18 uncontrolled, 4 controlled) with intravenous CyA, and 9 (all uncontrolled) using oral CyA. Only 4 controlled trials (one in abstract form) are available, and only one compares CyA to placebo. However, efficacy results are very consistent in these 4 trials, and very similar to those in observational studies. CyA achieves remission in 91,4% and 71.4% of patients in controlled and uncontrolled studies using intravenous route, and in 71,2% using oral route. Two mg/kg/day seems so efficacious and safer as previous standard 4 mg/kg/day dose. Minor side effects are rather common but do not seriously limit therapy. Severe side effects, specially infections, are uncommon but clinically relevant with several deaths reported.
CONCLUSION: CyA (intravenous, 2 mg/kg/day) constitutes an efficacious and relatively safe alternative in the treatment of severe, steroid-refractory, attack of UC. To optimize treatment, the correct selection of patients, a standardized protocol and clinical surveillance are recommended.

Best wishes
رد مع اقتباس
الرد

Bookmarks
  • Digg
  • del.icio.us
  • StumbleUpon
  • Google
  • Facebook
  • My Yahoo!
  • MySpace
  • Ma.gnolia
  • Furl
  • Reddit
  • NewsVine
  • Netscape
  • Slashdot
  • SphereIt
  • Feedmelinks
  • Technorati
أدوات الموضوع

 

المواضيع المشابهة
الموضوع مبتدئ الموضوع المنتدى الردود آخر مشاركة
Leukocytapheresis for treatment of IBD. Philip Hardo آخر المستجدات الطبية 0 Dec, 07 2005 14:10
treatment guidelines for TB/HIV infection Philip Hardo آخر المستجدات الطبية 0 Nov, 08 2005 16:42
TREATMENT OF ACUTE STROKE Philip Hardo آخر المستجدات الطبية 0 Nov, 07 2005 15:28
IV steroids in acute severe asthma Philip Hardo آخر المستجدات الطبية 0 Nov, 01 2005 11:21



تم توليد الصفحة خلال 0.11341 ثانية باستخدام 11 من الاستعلامات

Valid XHTML 1.0 Transitional Valid CSS! Get Firefox!! Add to Google

كل الأوقات حسب GMT +2، والوقت الآن 01:34.


Powered by vBulletin - Copyright ©2000 - 2008, Jelsoft Enterprises Ltd.
Content Relevant URLs by vBSEO 3.2.0 ©2008, Crawlability, Inc.
CMPS & Link Directory are powered by vBadvanced
Photo Gallery is Powered by PhotoPost vBGallery
Copyright ©2004 - 2008, Syrian Medical Society